Health Canada's VHP review process requires precise strain identification, documented safety, manufacturing consistency and substantiated claims.
Bacillus clausii 088AE met every requirement, setting a new benchmark for spore-forming probiotics in companion animal health.
For pet supplement brands, the distinction delivers meaningful differentiation in an increasingly crowded probiotic market.
VHP-listed ingredients provide added regulatory credibility for retailers, veterinarians and ingredient-conscious pet parents seeking science-backed formulations.
"With FDA GRAS status and Health Canada NPN-approved claims, Bacillus clausii 088AE has already established a strong regulatory and scientific foundation in human health," said Reshma Rathi, Vice President of Specialty Enzymes & Probiotics.
"VHP recognition brings that same level of credibility to the pet space and gives formulators a truly differentiated, science-backed probiotic strain."
Bacillus clausii 088AE is also a foundational strain in ProbioSEB CSC3 Pet, Specialty's three-strain spore-forming probiotic blend developed for companion animal formulations for gut and immune health.